Top Suppliers:I want be here
Related CAS#:
93000-03-4 2488-15-5
4434-61-1 4309-82-4
3601-66-9 3744-87-4
292642-79-6 200937-21-9
102185-35-3 144186-13-0

93000-03-4

93000-03-4 structure
93000-03-4 structure
Name 2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-methylsulfanylbutanoic acid
Synonyms Methionine, N-[(1,1-dimethylethoxy)carbonyl]-
BOC-DL-Methionine
N-{[(2-Methyl-2-propanyl)oxy]carbonyl}methionine
N-(tert-butoxycarbonyl)methionine
Boc-methionine
t-butoxycarbonylmethionine
2R-tert-Butoxycarbonylamino4-methylsulfanyl-butyric acid
Boc-Dl-Met-Oh
L-Methionine,N-[(1,1-dimethylethoxy)carbonyl]
2-(R,S)-2-[(tert-butoxycarbonyl)amino]-4-(methylsulfanyl)butanoic acid
N-tBoc-DL-methionine
EINECS 219-639-3
N-(t-butoxycarbonyl)-methionine
N-(tert-Butoxycarbonyl)-methionine
Description (tert-Butoxycarbonyl)methionine is a Methionine (HY-13694) derivative[1].
Related Catalog
In Vitro Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances[1].
References

[1]. Luckose F, et al. Effects of amino acid derivatives on physical, mental, and physiological activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-1144.
Density 1.2±0.1 g/cm3
Boiling Point 415.5±40.0 °C at 760 mmHg
Molecular Formula C10H19NO4S
Molecular Weight 249.327
Flash Point 205.1±27.3 °C
Exact Mass 249.103485
PSA 100.93000
LogP 2.15
Appearance Solid
Vapour Pressure 0.0±2.1 mmHg at 25°C
Index of Refraction 1.500
Storage condition Store at RT.
24424-99-5 structure

24424-99-5
59-51-8 structure

59-51-8

~84%

93000-03-4 structure

93000-03-4
Literature: Picha, Jan; Vanek, Vaclav; Budesinsky, Milos; Mladkova, Jana; Garrow, Timothy A.; Jiracek, Jiri European Journal of Medicinal Chemistry, 2013 , vol. 65, p. 256 - 275
909114-65-4 structure

909114-65-4
59-51-8 structure

59-51-8

~98%

93000-03-4 structure

93000-03-4
Literature: Hioki, Kazuhito; Kinugasa, Mizuho; Kishimoto, Michiko; Fujiwara, Miho; Tani, Shohei; Kunishima, Munetaka Synthesis, 2006 , # 12 p. 1931 - 1933
348-67-4 structure

348-67-4
24424-99-5 structure

24424-99-5

~%

93000-03-4 structure

93000-03-4
Literature: Glaxo Wellcome Inc. Patent: US5994344 A1, 1999 ;
59-51-8 structure

59-51-8
89037-64-9 structure

89037-64-9

~85%

93000-03-4 structure

93000-03-4
Literature: Kim, Sunggak; Chang, Heung Journal of the Chemical Society, Chemical Communications, 1983 , # 22 p. 1357 - 1358
75-44-5 structure

75-44-5
6297-53-6 structure

6297-53-6

~%

93000-03-4 structure

93000-03-4
Literature: McKay; Albertson Journal of the American Chemical Society, 1957 , vol. 79, p. 4686,4689
13303-10-1 structure

13303-10-1
59-51-8 structure

59-51-8

~%

93000-03-4 structure

93000-03-4
Literature: Anderson; McGregor Journal of the American Chemical Society, 1957 , vol. 79, p. 6180,6181

Chemsrc provides CAS#:93000-03-4 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 93000-03-4 | Chemsrc address: https://m.chemsrc.com/en/baike/907160.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved